Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
P.1.13 (Gamma)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.372ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.372ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.372NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.634ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.634ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.634ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.634NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.37.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.37.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.37.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.37.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.630ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.630ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.630ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.630NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.360ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.360ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.360ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.360NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.578ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.578ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.578ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.578NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.544ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.544ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.544ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.544NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.448ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.448ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.448ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.448NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.425ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.425ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.425ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.425NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.354ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.354ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.354ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.354NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.503ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.503ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.503ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.503NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36.31ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.31NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.623ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used